128 related articles for article (PubMed ID: 1357520)
1. Manipulation of dopamine receptors alters hypoxic pulmonary vasoconstriction in isolated perfused rat lungs.
Polak MJ; Kennedy LA; Drummond WH
Life Sci; 1992; 51(17):1317-23. PubMed ID: 1357520
[TBL] [Abstract][Full Text] [Related]
2. Effect of fenoldopam on preconstricted isolated salt-perfused rat lungs.
Polak MJ; Knight ME; Gause GE; Bucciarelli RL; Drummond W
J Appl Physiol (1985); 1989 Sep; 67(3):1076-80. PubMed ID: 2571605
[TBL] [Abstract][Full Text] [Related]
3. Functional ontogeny of pulmonary vascular DA1 dopamine receptors in the isolated perfused rabbit lung.
Polak MJ; Taylor DA
Pediatr Res; 1994 Feb; 35(2):228-32. PubMed ID: 7909367
[TBL] [Abstract][Full Text] [Related]
4. DA1 dopamine receptors in renal cortical collecting duct.
Ohbu K; Felder RA
Am J Physiol; 1991 Nov; 261(5 Pt 2):F890-5. PubMed ID: 1683170
[TBL] [Abstract][Full Text] [Related]
5. Systemic and pulmonary vascular effects of selective dopamine receptor blockade and stimulation in lambs.
Polak MJ; Drummond WH
Pediatr Res; 1993 Feb; 33(2):181-4. PubMed ID: 8094550
[TBL] [Abstract][Full Text] [Related]
6. Dopamine DA1 receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats.
Wang YX; Gellai M; Brooks DP
Am J Physiol; 1992 Jun; 262(6 Pt 2):F1055-60. PubMed ID: 1352429
[TBL] [Abstract][Full Text] [Related]
7. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
Grenader A; Healy DP
J Pharmacol Exp Ther; 1991 Jul; 258(1):193-8. PubMed ID: 1677038
[TBL] [Abstract][Full Text] [Related]
8. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
Clark KL; Hilditch A; Robertson MJ; Drew GM
J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect of lithium on the renal response to DA1-dopamine receptor stimulation by fenoldopam in normal man.
Girbes AR; Smit AJ; Meijer S; Reitsma WD
Br J Clin Pharmacol; 1990 Apr; 29(4):413-5. PubMed ID: 1970264
[TBL] [Abstract][Full Text] [Related]
10. The pharmacology of fenoldopam.
Nichols AJ; Ruffolo RR; Brooks DP
Am J Hypertens; 1990 Jun; 3(6 Pt 2):116S-119S. PubMed ID: 1974439
[TBL] [Abstract][Full Text] [Related]
11. Effects of the dopamine receptor agonists, fenoldopam and quinpirole, in the rat stomach.
Lefebvre RA; Guenaneche F; De Beurme FA
Eur J Pharmacol; 1990 Aug; 185(1):69-79. PubMed ID: 1977599
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro.
Edwards RM
Eur J Pharmacol; 1986 Jul; 126(1-2):167-70. PubMed ID: 2875883
[TBL] [Abstract][Full Text] [Related]
13. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I
J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
[TBL] [Abstract][Full Text] [Related]
14. Response to dopamine agonists of the rat isolated uterus.
Estañ L; Berenguer A; Martinez-Mir I; Rubio E; Morales-Olivas FJ
Gen Pharmacol; 1993 Mar; 24(2):397-401. PubMed ID: 8097743
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam.
Christie MI; Smith GW
J Pharmacol Exp Ther; 1994 Feb; 268(2):565-70. PubMed ID: 7906731
[TBL] [Abstract][Full Text] [Related]
16. Ontogeny of renal response to specific dopamine DA1-receptor stimulation in sheep.
Segar JL; Smith FG; Guillery EN; Jose PA; Robillard JE
Am J Physiol; 1992 Oct; 263(4 Pt 2):R868-73. PubMed ID: 1357989
[TBL] [Abstract][Full Text] [Related]
17. 5-Hydroxytryptamine receptor activity of the dopamine receptor agonist fenoldopam in canine tracheal smooth muscle.
Gretler DD; Jones KC; Murphy MB
J Pharmacol Exp Ther; 1992 Feb; 260(2):491-8. PubMed ID: 1346635
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the agonist activity of fenoldopam (SKF 82526) at the vascular 5-HT2 receptor.
Christie MI; Harper D; Smith GW
Br J Pharmacol; 1992 Dec; 107(4):1008-12. PubMed ID: 1361397
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of SK&F R-105058 and R-106114, N-ethyl carbamate ester prodrugs of fenoldopam.
Brooks DP; DePalma PD; Cyronak MJ; Karpinski K; Weinstock J
Pharmacology; 1990; 41(5):299-308. PubMed ID: 1982634
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Na+,K(+)-ATPase in rat renal proximal tubules by dopamine involved DA-1 receptor activation.
Chen C; Lokhandwala MF
Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):289-95. PubMed ID: 8097567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
